Hong-Wei Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hong-Wei Pan has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Zheng-Yu Liu
Cardiology Department, Hunan Provincial People’s Hospital, Changsha, China
6 shared publications Peng-Fei Zheng
Cardiology Department, Hunan Provincial People’s Hospital, Furong, Changsha 410000, Hunan, China
5 shared publications- Peng Liu
Cardiology Department, Hunan Provincial People’s Hospital, Changsha, China
3 shared publications Zhao-Fen Zheng
Cardiology Department, Hunan Provincial People’s Hospital, Furong, Changsha 410000, Hunan, China
3 shared publicationsJing-Jing Rong
Cardiology Department, Hunan Provincial People’s Hospital
2 shared publicationsLu-Zhu Chen
Department of Cardiology, Hunan Provincial People's Hospital, Changsha, China
2 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1864957
MGST3 defines a mitochondrial-health-associated M2 macrophage state in atherosclerosis: integrative multi-omics, single-cell mediation, and functional validation
Background: Mitochondrial dysfunction is increasingly recognized as a driver of maladaptive macrophage polarization in atherosclerosis (AS), but the mitochondrial genes that shape disease-relevant macrophage states remain poorly defined. Methods: We integrated weighted gene co-expression network analysis (WGCNA), machine learning, two-sample Mendelian randomization (two-sample MR), bulk transcriptomics, single-cell analysis, disease-level validation, single-cell mediation, and in vitro perturbation to identify macrophage-relevant mitochondrial regulators in AS. Results: Eight candidate genes were consistently prioritized by WGCNA and machine learning; among them, microsomal glutathione S-transferase 3 (MGST3) showed the strongest protective genetic signal. Two-sample MR supported a protective association between genetically predicted MGST3 expression and coronary artery disease/coronary heart disease risk (training set OR = 0.989, 95% CI 0.978-0.999, P = 0.042; test set OR = 0.977, 95% CI 0.960-0.995, P = 0.013). Human carotid plaque validation confirmed reduced MGST3 at both mRNA and protein levels in AS lesions. Notably, despite this whole-plaque downregulation, single-cell and disease-level analyses revealed an expanded MGST3-high M2-like macrophage state in AS, suggesting a compensatory protective macrophage program within diseased plaques. MGST3-high M2-like cells displayed an OXPHOS-oriented, antioxidant, and less inflammatory transcriptional state, acted as an active signaling population, and showed higher composite MitoHealth scores. Single-cell mediation analysis further indicated that MitoHealth statistically links higher MGST3 expression to lower inflammatory activity, lower M1-like polarization, and lower atherogenic macrophage programming. In M2-polarized macrophages, MGST3 knockdown reduced M2-associated and mitochondrial/antioxidant transcripts while increasing pro-inflammatory transcripts, providing transcript-level functional support. PheWAS analysis detected no significant phenotype associations at the predefined threshold. Conclusions: These findings define MGST3 as a marker of a mitochondrial-health-associated M2-like macrophage state that appears expanded within AS plaques despite reduced whole-plaque MGST3 expression. The MGST3-MitoHealth axis may represent a compensatory macrophage program linked to mitochondrial preservation and lower pro-atherogenic activation, warranting further diagnostic and therapeutic investigation in AS.
- 17 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1864957
Open AccessMGST3 defines a mitochondrial-health-associated M2 macrophage state in atherosclerosis: integrative multi-omics, single-cell mediation, and functional validation
Background: Mitochondrial dysfunction is increasingly recognized as a driver of maladaptive macrophage polarization in atherosclerosis (AS), but the mitochondrial genes that shape disease-relevant macrophage states remain poorly defined. Methods: We integrated weighted gene co-expression network analysis (WGCNA), machine learning, two-sample Mendelian randomization (two-sample MR), bulk transcriptomics, single-cell analysis, disease-level validation, single-cell mediation, and in vitro perturbation to identify macrophage-relevant mitochondrial regulators in AS. Results: Eight candidate genes were consistently prioritized by WGCNA and machine learning; among them, microsomal glutathione S-transferase 3 (MGST3) showed the strongest protective genetic signal. Two-sample MR supported a protective association between genetically predicted MGST3 expression and coronary artery disease/coronary heart disease risk (training set OR = 0.989, 95% CI 0.978-0.999, P = 0.042; test set OR = 0.977, 95% CI 0.960-0.995, P = 0.013). Human carotid plaque validation confirmed reduced MGST3 at both mRNA and protein levels in AS lesions. Notably, despite this whole-plaque downregulation, single-cell and disease-level analyses revealed an expanded MGST3-high M2-like macrophage state in AS, suggesting a compensatory protective macrophage program within diseased plaques. MGST3-high M2-like cells displayed an OXPHOS-oriented, antioxidant, and less inflammatory transcriptional state, acted as an active signaling population, and showed higher composite MitoHealth scores. Single-cell mediation analysis further indicated that MitoHealth statistically links higher MGST3 expression to lower inflammatory activity, lower M1-like polarization, and lower atherogenic macrophage programming. In M2-polarized macrophages, MGST3 knockdown reduced M2-associated and mitochondrial/antioxidant transcripts while increasing pro-inflammatory transcripts, providing transcript-level functional support. PheWAS analysis detected no significant phenotype associations at the predefined threshold. Conclusions: These findings define MGST3 as a marker of a mitochondrial-health-associated M2-like macrophage state that appears expanded within AS plaques despite reduced whole-plaque MGST3 expression. The MGST3-MitoHealth axis may represent a compensatory macrophage program linked to mitochondrial preservation and lower pro-atherogenic activation, warranting further diagnostic and therapeutic investigation in AS.
- Open Access
- 1 July 2026
- Published by Frontiers Media SA in Frontiers in Bioinformatics
- Vol. 6, 1873526
A multi-scale biological network framework for discovering MiRNA-Disease associations
Introduction: Identifying potential miRNA–disease associations is essential for clarifying the molecular basis of complex diseases and accelerating the discovery of diagnostic biomarkers and therapeutic targets. However, the performance of existing computational methods is often limited by sparse biological interaction networks, highly imbalanced disease distributions, and the small number of experimentally validated associations. Methods: To address these challenges, we propose MMAG, a novel framework that formulates miRNA–disease association prediction as a meta-conditional distribution alignment problem on multi-scale biological graphs. MMAG integrates three complementary components. First, a multi-scale representation learning module captures hierarchical biological information from local topological connectivity, mesoscopic functional organization, and global spectral structure. Second, a meta-learning strategy models each disease as an individual task, enabling the model to learn disease-specific prototype representations from support samples and adapt effectively to few-shot settings. Third, a conditional adversarial alignment mechanism reduces feature distribution discrepancies across diseases with different data scales, thereby enhancing cross-task knowledge transfer and generalization. Results: Extensive experiments demonstrate that MMAG consistently outperforms several state-of-the-art methods under few-shot, long-tailed, and cross-dataset transfer scenarios. Discussion: These results indicate that MMAG provides an effective and scalable solution for miRNA–disease association prediction and offers a promising strategy for broader biological network inference tasks.
- 1 July 2026
- Published by Frontiers Media SA in Frontiers in Bioinformatics
- Vol. 6, 1873526
Open AccessA multi-scale biological network framework for discovering MiRNA-Disease associations
Introduction: Identifying potential miRNA–disease associations is essential for clarifying the molecular basis of complex diseases and accelerating the discovery of diagnostic biomarkers and therapeutic targets. However, the performance of existing computational methods is often limited by sparse biological interaction networks, highly imbalanced disease distributions, and the small number of experimentally validated associations. Methods: To address these challenges, we propose MMAG, a novel framework that formulates miRNA–disease association prediction as a meta-conditional distribution alignment problem on multi-scale biological graphs. MMAG integrates three complementary components. First, a multi-scale representation learning module captures hierarchical biological information from local topological connectivity, mesoscopic functional organization, and global spectral structure. Second, a meta-learning strategy models each disease as an individual task, enabling the model to learn disease-specific prototype representations from support samples and adapt effectively to few-shot settings. Third, a conditional adversarial alignment mechanism reduces feature distribution discrepancies across diseases with different data scales, thereby enhancing cross-task knowledge transfer and generalization. Results: Extensive experiments demonstrate that MMAG consistently outperforms several state-of-the-art methods under few-shot, long-tailed, and cross-dataset transfer scenarios. Discussion: These results indicate that MMAG provides an effective and scalable solution for miRNA–disease association prediction and offers a promising strategy for broader biological network inference tasks.
- Open Access
- 9 July 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 1-11
The association of life’s essential 8 with prevalence of chronic respiratory diseases in adults: insights from NHANES 2007–2018
Chronic respiratory diseases (CRDs) and cardiovascular diseases (CVD) share common risk factors and frequently co-occur, leading to poorer outcomes. Life’s Essential 8 (LE8), a novel metric for cardiovascular health, may provide insights into this association. This study investigates the relationship between LE8 and CRDs to identify modifiable factors for targeted prevention. We analyzed data from the National Health and Nutrition Examination Survey (NHANES), including adults aged 20 years or older. The LE8 score was calculated based on eight indicators: four health behaviors (diet, physical activity, nicotine exposure, and sleep health) and four health factors (body mass index, blood lipids, blood glucose, and blood pressure). CRDs were assessed using a questionnaire-based approach. Multivariable logistic regression and restricted cubic spline models were employed to examine the association between LE8 score and CRDs, adjusting for potential confounders. Subgroup analyses and machine learning models were also conducted. Among 20,537 participants included (mean age, 48.02 ± 16.73 years), 10,492 (51.08%) were female and 3812 (18.56%) were determined to have CRDs. The mean LE8 score of the study population was 68.72 ± 14.44. After the adjustment of potential confounders, higher LE8 scores were associated with reduced odds of CRDs (OR:0.77, CI:0.55–0.92), with a nonlinear dose–response relationship observed. A similar pattern was also identified in the association of health factor scores with CRDs, while health behavior showed a linear dose–response relationship with CRDs. Subgroup analyses revealed consistent associations across different ethnicities, education levels, and the presence of cardiovascular disease. Machine learning models identified smoking and LE8 score as the top two factors associated with CRDs. This study demonstrates a negative, nonlinear association between LE8 and health factor scores and the presence of CRDs. Our findings suggest that maintaining cardiovascular health, as quantified by the LE8 score, holds potential as a strategic approach for the prevention and management of CRDs.
- 9 July 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 1-11
Open AccessThe association of life’s essential 8 with prevalence of chronic respiratory diseases in adults: insights from NHANES 2007–2018
Chronic respiratory diseases (CRDs) and cardiovascular diseases (CVD) share common risk factors and frequently co-occur, leading to poorer outcomes. Life’s Essential 8 (LE8), a novel metric for cardiovascular health, may provide insights into this association. This study investigates the relationship between LE8 and CRDs to identify modifiable factors for targeted prevention. We analyzed data from the National Health and Nutrition Examination Survey (NHANES), including adults aged 20 years or older. The LE8 score was calculated based on eight indicators: four health behaviors (diet, physical activity, nicotine exposure, and sleep health) and four health factors (body mass index, blood lipids, blood glucose, and blood pressure). CRDs were assessed using a questionnaire-based approach. Multivariable logistic regression and restricted cubic spline models were employed to examine the association between LE8 score and CRDs, adjusting for potential confounders. Subgroup analyses and machine learning models were also conducted. Among 20,537 participants included (mean age, 48.02 ± 16.73 years), 10,492 (51.08%) were female and 3812 (18.56%) were determined to have CRDs. The mean LE8 score of the study population was 68.72 ± 14.44. After the adjustment of potential confounders, higher LE8 scores were associated with reduced odds of CRDs (OR:0.77, CI:0.55–0.92), with a nonlinear dose–response relationship observed. A similar pattern was also identified in the association of health factor scores with CRDs, while health behavior showed a linear dose–response relationship with CRDs. Subgroup analyses revealed consistent associations across different ethnicities, education levels, and the presence of cardiovascular disease. Machine learning models identified smoking and LE8 score as the top two factors associated with CRDs. This study demonstrates a negative, nonlinear association between LE8 and health factor scores and the presence of CRDs. Our findings suggest that maintaining cardiovascular health, as quantified by the LE8 score, holds potential as a strategic approach for the prevention and management of CRDs.
- Open Access
- 22 September 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (18) , 9797-9808
Investigating the causal effect of Dickkopf-1 on coronary artery disease and ischemic stroke: a Mendelian randomization study
Epidemiological investigations have indicated a correlation between elevated plasma levels of Dickkopf-related protein 1 (DKK1) and the presence of atherosclerosis. However, the exact causal relationship of DKK1 with the development of coronary artery disease (CAD) and ischemic stroke (IS) remains unclear. To address this gap, our study aimed to explore their causal association using a two-sample Mendelian randomization (MR) approach. We obtained summary statistics from genome-wide association studies (GWAS) meta-analyses conducted by Folkersen et al. and Nikpay et al., which included data from 21,758 individuals for DKK1 and 42,096 cases of CAD. Additionally, we obtained data from the FinnGen biobank analysis round 5, which included 10,551 cases of IS. Eight MR methods were employed to estimate causal effects and detect directional pleiotropy. Our findings demonstrated that genetic liability to DKK1 was associated with increased risks of CAD (odds ratio [OR]: 1.087; 95% confidence interval [CI]: 1.024–1.154; P = 0.006) and IS (OR: 1.096; 95% CI: 1.004–1.195; P = 0.039). These results establish a causal link between genetic liability to DKK1 and elevated risks of CAD and IS. Consequently, DKK1 may represent a promising therapeutic target for the prevention and treatment of CAD and IS.
- 22 September 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (18) , 9797-9808
Open AccessInvestigating the causal effect of Dickkopf-1 on coronary artery disease and ischemic stroke: a Mendelian randomization study
Epidemiological investigations have indicated a correlation between elevated plasma levels of Dickkopf-related protein 1 (DKK1) and the presence of atherosclerosis. However, the exact causal relationship of DKK1 with the development of coronary artery disease (CAD) and ischemic stroke (IS) remains unclear. To address this gap, our study aimed to explore their causal association using a two-sample Mendelian randomization (MR) approach. We obtained summary statistics from genome-wide association studies (GWAS) meta-analyses conducted by Folkersen et al. and Nikpay et al., which included data from 21,758 individuals for DKK1 and 42,096 cases of CAD. Additionally, we obtained data from the FinnGen biobank analysis round 5, which included 10,551 cases of IS. Eight MR methods were employed to estimate causal effects and detect directional pleiotropy. Our findings demonstrated that genetic liability to DKK1 was associated with increased risks of CAD (odds ratio [OR]: 1.087; 95% confidence interval [CI]: 1.024–1.154; P = 0.006) and IS (OR: 1.096; 95% CI: 1.004–1.195; P = 0.039). These results establish a causal link between genetic liability to DKK1 and elevated risks of CAD and IS. Consequently, DKK1 may represent a promising therapeutic target for the prevention and treatment of CAD and IS.
- Open Access
- 27 February 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (5) , 1475-1495
Identification MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 as the potential immune-related key genes involved in ischaemic cardiomyopathy by random forest and nomogram
The immune molecular mechanisms involved in ischaemic cardiomyopathy (ICM) have not been fully elucidated. The current study aimed to elucidate the immune cell infiltration pattern of the ICM and identify key immune-related genes that participate in the pathologic process of the ICM. The differentially expressed genes (DEGs) were identified from two datasets (GSE42955 combined with GSE57338) and the top 8 key DEGs related to ICM were screened using random forest and used to construct the nomogram model. Moreover, the “CIBERSORT” software package was used to determine the proportion of infiltrating immune cells in the ICM. A total of 39 DEGs (18 upregulated and 21 downregulated) were identified in the current study. Four upregulated DEGs, including MNS1, FRZB, OGN, and LUM, and four downregulated DEGs, SERP1NA3, RNASE2, FCN3 and SLCO4A1, were identified by the random forest model. The nomogram constructed based on the above 8 key genes suggested a diagnostic value of up to 99% to distinguish the ICM from healthy participants. Meanwhile, most of the key DEGs presented prominent interactions with immune cell infiltrates. The RT-qPCR results suggested that the expression levels of MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 between the ICM and control groups were consistent with the bioinformatic analysis results. These results suggested that immune cell infiltration plays a critical role in the occurrence and progression of ICM. Several key immune-related genes, including the MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 genes, are expected to be reliable serum markers for the diagnosis of ICM and potential molecular targets for ICM immunotherapy.
- 27 February 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (5) , 1475-1495
Open AccessIdentification MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 as the potential immune-related key genes involved in ischaemic cardiomyopathy by random forest and nomogram
The immune molecular mechanisms involved in ischaemic cardiomyopathy (ICM) have not been fully elucidated. The current study aimed to elucidate the immune cell infiltration pattern of the ICM and identify key immune-related genes that participate in the pathologic process of the ICM. The differentially expressed genes (DEGs) were identified from two datasets (GSE42955 combined with GSE57338) and the top 8 key DEGs related to ICM were screened using random forest and used to construct the nomogram model. Moreover, the “CIBERSORT” software package was used to determine the proportion of infiltrating immune cells in the ICM. A total of 39 DEGs (18 upregulated and 21 downregulated) were identified in the current study. Four upregulated DEGs, including MNS1, FRZB, OGN, and LUM, and four downregulated DEGs, SERP1NA3, RNASE2, FCN3 and SLCO4A1, were identified by the random forest model. The nomogram constructed based on the above 8 key genes suggested a diagnostic value of up to 99% to distinguish the ICM from healthy participants. Meanwhile, most of the key DEGs presented prominent interactions with immune cell infiltrates. The RT-qPCR results suggested that the expression levels of MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 between the ICM and control groups were consistent with the bioinformatic analysis results. These results suggested that immune cell infiltration plays a critical role in the occurrence and progression of ICM. Several key immune-related genes, including the MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 genes, are expected to be reliable serum markers for the diagnosis of ICM and potential molecular targets for ICM immunotherapy.
- Open Access
- 20 February 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (5) , 1371-1393
Identification of m6A regulator-mediated RNA methylation modification patterns and key immune-related genes involved in atrial fibrillation
The role of m6A in the regulation of the immune microenvironment in atrial fibrillation (AF) remains unclear. This study systematically evaluated the RNA modification patterns mediated by differential m6A regulators in 62 AF samples, identified the pattern of immune cell infiltration in AF and identified several immune-related genes associated with AF. A total of six key differential m6A regulators between healthy subjects and AF patients were identified by the random forest classifier. Three distinct RNA modification patterns (m6A cluster-A, -B and -C) among AF samples were identified based on the expression of 6 key m6A regulators. Differential infiltrating immune cells and HALLMARKS signaling pathways between normal and AF samples as well as among samples with three distinct m6A modification patterns were identified. A total of 16 overlapping key genes were identified by weighted gene coexpression network analysis (WGCNA) combined with two machine learning methods. The expression levels of the NCF2 and NCST genes were different between controls and AF patient samples as well as among samples with the distinct m6A modification patterns. RT-qPCR also proved that the expression of NCF2 and NCST was significantly increased in AF patients compared with control participants. These results suggested that m6A modification plays a key role in the complexity and diversity of the immune microenvironment of AF. Immunotyping of patients with AF will help to develop more accurate immunotherapy strategies for those with a significant immune response. The NCF2 and NCST genes may be novel biomarkers for the accurate diagnosis and immunotherapy of AF.
- 20 February 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (5) , 1371-1393
Open AccessIdentification of m6A regulator-mediated RNA methylation modification patterns and key immune-related genes involved in atrial fibrillation
The role of m6A in the regulation of the immune microenvironment in atrial fibrillation (AF) remains unclear. This study systematically evaluated the RNA modification patterns mediated by differential m6A regulators in 62 AF samples, identified the pattern of immune cell infiltration in AF and identified several immune-related genes associated with AF. A total of six key differential m6A regulators between healthy subjects and AF patients were identified by the random forest classifier. Three distinct RNA modification patterns (m6A cluster-A, -B and -C) among AF samples were identified based on the expression of 6 key m6A regulators. Differential infiltrating immune cells and HALLMARKS signaling pathways between normal and AF samples as well as among samples with three distinct m6A modification patterns were identified. A total of 16 overlapping key genes were identified by weighted gene coexpression network analysis (WGCNA) combined with two machine learning methods. The expression levels of the NCF2 and NCST genes were different between controls and AF patient samples as well as among samples with the distinct m6A modification patterns. RT-qPCR also proved that the expression of NCF2 and NCST was significantly increased in AF patients compared with control participants. These results suggested that m6A modification plays a key role in the complexity and diversity of the immune microenvironment of AF. Immunotyping of patients with AF will help to develop more accurate immunotherapy strategies for those with a significant immune response. The NCF2 and NCST genes may be novel biomarkers for the accurate diagnosis and immunotherapy of AF.
- Open Access
- 12 August 2022
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 20 (1) , 1-17
Identification of immune-related key genes in the peripheral blood of ischaemic stroke patients using a weighted gene coexpression network analysis and machine learning
Background: The immune system plays a vital role in the pathological process of ischaemic stroke. However, the exact immune-related mechanism remains unclear. The current research aimed to identify immune-related key genes associated with ischaemic stroke. Methods: CIBERSORT was utilized to reveal the immune cell infiltration pattern in ischaemic stroke patients. Meanwhile, a weighted gene coexpression network analysis (WGCNA) was utilized to identify meaningful modules significantly correlated with ischaemic stroke. The characteristic genes correlated with ischaemic stroke were identified by the following two machine learning methods: the support vector machine-recursive feature elimination (SVM-RFE) algorithm and least absolute shrinkage and selection operator (LASSO) logistic regression. Results: The CIBERSORT results suggested that there was a decreased infiltration of naive CD4 T cells, CD8 T cells, resting mast cells and eosinophils and an increased infiltration of neutrophils, M0 macrophages and activated memory CD4 T cells in ischaemic stroke patients. Then, three significant modules (pink, brown and cyan) were identified to be significantly associated with ischaemic stroke. The gene enrichment analysis indicated that 519 genes in the above three modules were mainly involved in several inflammatory or immune-related signalling pathways and biological processes. Eight hub genes (ADM, ANXA3, CARD6, CPQ, SLC22A4, UBE2S, VIM and ZFP36) were revealed to be significantly correlated with ischaemic stroke by the LASSO logistic regression and SVM-RFE algorithm. The external validation combined with a RT‒qPCR analysis revealed that the expression levels of ADM, ANXA3, SLC22A4 and VIM were significantly increased in ischaemic stroke patients and that these key genes were positively associated with neutrophils and M0 macrophages and negatively correlated with CD8 T cells. The mean AUC value of ADM, ANXA3, SLC22A4 and VIM was 0.80, 0.87, 0.91 and 0.88 in the training set, 0.85, 0.77, 0.86 and 0.72 in the testing set and 0.87, 0.83, 0.88 and 0.91 in the validation samples, respectively. Conclusions: These results suggest that the ADM, ANXA3, SLC22A4 and VIM genes are reliable serum markers for the diagnosis of ischaemic stroke and that immune cell infiltration plays a crucial role in the occurrence and development of ischaemic stroke.
- 12 August 2022
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 20 (1) , 1-17
Open AccessIdentification of immune-related key genes in the peripheral blood of ischaemic stroke patients using a weighted gene coexpression network analysis and machine learning
Background: The immune system plays a vital role in the pathological process of ischaemic stroke. However, the exact immune-related mechanism remains unclear. The current research aimed to identify immune-related key genes associated with ischaemic stroke. Methods: CIBERSORT was utilized to reveal the immune cell infiltration pattern in ischaemic stroke patients. Meanwhile, a weighted gene coexpression network analysis (WGCNA) was utilized to identify meaningful modules significantly correlated with ischaemic stroke. The characteristic genes correlated with ischaemic stroke were identified by the following two machine learning methods: the support vector machine-recursive feature elimination (SVM-RFE) algorithm and least absolute shrinkage and selection operator (LASSO) logistic regression. Results: The CIBERSORT results suggested that there was a decreased infiltration of naive CD4 T cells, CD8 T cells, resting mast cells and eosinophils and an increased infiltration of neutrophils, M0 macrophages and activated memory CD4 T cells in ischaemic stroke patients. Then, three significant modules (pink, brown and cyan) were identified to be significantly associated with ischaemic stroke. The gene enrichment analysis indicated that 519 genes in the above three modules were mainly involved in several inflammatory or immune-related signalling pathways and biological processes. Eight hub genes (ADM, ANXA3, CARD6, CPQ, SLC22A4, UBE2S, VIM and ZFP36) were revealed to be significantly correlated with ischaemic stroke by the LASSO logistic regression and SVM-RFE algorithm. The external validation combined with a RT‒qPCR analysis revealed that the expression levels of ADM, ANXA3, SLC22A4 and VIM were significantly increased in ischaemic stroke patients and that these key genes were positively associated with neutrophils and M0 macrophages and negatively correlated with CD8 T cells. The mean AUC value of ADM, ANXA3, SLC22A4 and VIM was 0.80, 0.87, 0.91 and 0.88 in the training set, 0.85, 0.77, 0.86 and 0.72 in the testing set and 0.87, 0.83, 0.88 and 0.91 in the validation samples, respectively. Conclusions: These results suggest that the ADM, ANXA3, SLC22A4 and VIM genes are reliable serum markers for the diagnosis of ischaemic stroke and that immune cell infiltration plays a crucial role in the occurrence and development of ischaemic stroke.
- Open Access
- 27 July 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 922523
Integrative identification of immune-related key genes in atrial fibrillation using weighted gene coexpression network analysis and machine learning
Background: The immune system significantly participates in the pathologic process of atrial fibrillation (AF). However, the molecular mechanisms underlying this participation are not completely explained. The current research aimed to identify critical genes and immune cells that participate in the pathologic process of AF.Methods: CIBERSORT was utilized to reveal the immune cell infiltration pattern in AF patients. Meanwhile, weighted gene coexpression network analysis (WGCNA) was utilized to identify meaningful modules that were significantly correlated with AF. The characteristic genes correlated with AF were identified by the least absolute shrinkage and selection operator (LASSO) logistic regression and support vector machine recursive feature elimination (SVM-RFE) algorithm.Results: In comparison to sinus rhythm (SR) individuals, we observed that fewer activated mast cells and regulatory T cells (Tregs), as well as more gamma delta T cells, resting mast cells, and M2 macrophages, were infiltrated in AF patients. Three significant modules (pink, red, and magenta) were identified to be significantly associated with AF. Gene enrichment analysis showed that all 717 genes were associated with immunity- or inflammation-related pathways and biological processes. Four hub genes (GALNT16, HTR2B, BEX2, and RAB8A) were revealed to be significantly correlated with AF by the SVM-RFE algorithm and LASSO logistic regression. qRT–PCR results suggested that compared to the SR subjects, AF patients exhibited significantly reduced BEX2 and GALNT16 expression, as well as dramatically elevated HTR2B expression. The AUC measurement showed that the diagnostic efficiency of BEX2, HTR2B, and GALNT16 in the training set was 0.836, 0.883, and 0.893, respectively, and 0.858, 0.861, and 0.915, respectively, in the validation set.Conclusions: Three novel genes, BEX2, HTR2B, and GALNT16, were identified by WGCNA combined with machine learning, which provides potential new therapeutic targets for the early diagnosis and prevention of AF.
- 27 July 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 922523
Open AccessIntegrative identification of immune-related key genes in atrial fibrillation using weighted gene coexpression network analysis and machine learning
Background: The immune system significantly participates in the pathologic process of atrial fibrillation (AF). However, the molecular mechanisms underlying this participation are not completely explained. The current research aimed to identify critical genes and immune cells that participate in the pathologic process of AF.Methods: CIBERSORT was utilized to reveal the immune cell infiltration pattern in AF patients. Meanwhile, weighted gene coexpression network analysis (WGCNA) was utilized to identify meaningful modules that were significantly correlated with AF. The characteristic genes correlated with AF were identified by the least absolute shrinkage and selection operator (LASSO) logistic regression and support vector machine recursive feature elimination (SVM-RFE) algorithm.Results: In comparison to sinus rhythm (SR) individuals, we observed that fewer activated mast cells and regulatory T cells (Tregs), as well as more gamma delta T cells, resting mast cells, and M2 macrophages, were infiltrated in AF patients. Three significant modules (pink, red, and magenta) were identified to be significantly associated with AF. Gene enrichment analysis showed that all 717 genes were associated with immunity- or inflammation-related pathways and biological processes. Four hub genes (GALNT16, HTR2B, BEX2, and RAB8A) were revealed to be significantly correlated with AF by the SVM-RFE algorithm and LASSO logistic regression. qRT–PCR results suggested that compared to the SR subjects, AF patients exhibited significantly reduced BEX2 and GALNT16 expression, as well as dramatically elevated HTR2B expression. The AUC measurement showed that the diagnostic efficiency of BEX2, HTR2B, and GALNT16 in the training set was 0.836, 0.883, and 0.893, respectively, and 0.858, 0.861, and 0.915, respectively, in the validation set.Conclusions: Three novel genes, BEX2, HTR2B, and GALNT16, were identified by WGCNA combined with machine learning, which provides potential new therapeutic targets for the early diagnosis and prevention of AF.
- Open Access
- 10 May 2022
- Published by Impact Journals, LLC in Aging
- Vol. 14 (9) , 4085-4106
A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction
Despite the well-established role of long non-coding RNAs (lncRNAs) across various biological processes, their mechanisms in acute myocardial infarction (AMI) are not fully elucidated. The GSE34198 dataset from the Gene Expression Omnibus (GEO) database, which comprised 49 specimens from individuals with AMI and 47 specimens from controls, was extracted and analysed using the weighted gene co-expression network analysis (WGCNA) package. Twenty-seven key genes were identified through a combination of the degree and gene significance (GS) values, and the CDC42 (degree = 64), JAK2 (degree = 41), and CHUK (degree = 30) genes were identified as having the top three-degree values among the 27 genes. Potential interactions between lncRNA, miRNAs and mRNAs were predicted using the starBase V3.0 database, and a lncRNA-miRNA-mRNA triple network containing the lncRNA XIST, twenty-one miRNAs and three hub genes (CDC42, JAK2 and CHUK) was identified. RT–qPCR validation showed that the expression of the JAK2 and CDC42 genes and the lncRNA XIST was noticeably increased in samples from patients with AMI compared to normal samples. Pearson’s correlation analysis also proved that JAK2 and CDC42 expression levels correlated positively with lncRNA XIST expression levels. The area under ROC curve (AUC) of lncRNA XIST was 0.886, and the diagnostic efficacy of the lncRNA XIST was significantly better than that of JAK2 and CDC42. The results suggested that the lncRNA XIST appears to be a risk factor for AMI likely through its ability to regulate JAK2 and CDC42 gene expressions, and it is expected to be a novel and reliable biomarker for the diagnosis of AMI.
- 10 May 2022
- Published by Impact Journals, LLC in Aging
- Vol. 14 (9) , 4085-4106
Open AccessA novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction
Despite the well-established role of long non-coding RNAs (lncRNAs) across various biological processes, their mechanisms in acute myocardial infarction (AMI) are not fully elucidated. The GSE34198 dataset from the Gene Expression Omnibus (GEO) database, which comprised 49 specimens from individuals with AMI and 47 specimens from controls, was extracted and analysed using the weighted gene co-expression network analysis (WGCNA) package. Twenty-seven key genes were identified through a combination of the degree and gene significance (GS) values, and the CDC42 (degree = 64), JAK2 (degree = 41), and CHUK (degree = 30) genes were identified as having the top three-degree values among the 27 genes. Potential interactions between lncRNA, miRNAs and mRNAs were predicted using the starBase V3.0 database, and a lncRNA-miRNA-mRNA triple network containing the lncRNA XIST, twenty-one miRNAs and three hub genes (CDC42, JAK2 and CHUK) was identified. RT–qPCR validation showed that the expression of the JAK2 and CDC42 genes and the lncRNA XIST was noticeably increased in samples from patients with AMI compared to normal samples. Pearson’s correlation analysis also proved that JAK2 and CDC42 expression levels correlated positively with lncRNA XIST expression levels. The area under ROC curve (AUC) of lncRNA XIST was 0.886, and the diagnostic efficacy of the lncRNA XIST was significantly better than that of JAK2 and CDC42. The results suggested that the lncRNA XIST appears to be a risk factor for AMI likely through its ability to regulate JAK2 and CDC42 gene expressions, and it is expected to be a novel and reliable biomarker for the diagnosis of AMI.
- 25 March 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 97 (S2) , 1072-1079
Zero contrast optical coherence tomography‐guided percutaneous coronary intervention in patients with non‐ST segment elevation myocardial infarction and chronic kidney disease
Objectives: To investigate a strategy for ultra‐low volume contrast percutaneous coronary intervention (PCI) with the aims of preserving renal function and observing the 90‐day clinical endpoint in patients with non‐ST‐elevated myocardial infarction (non‐STEMI) and chronic kidney disease (CKD).Background: The feasibility, safety, and clinical utility of PCI with ultra‐low radio‐contrast medium in patients with non‐STEMI and CKD are unknown.Methods: A total of 29 patients with non‐STEMI and CKD (estimated glomerular filtration rate [eGFR] of ≤60 ml/min/1.73 m2) were included. Ultra‐low volume contrast PCI was performed after minimal contrast coronary angiography using zero contrast optical coherence tomography (OCT) guidance. Pre‐ and post‐PCI angiographic measurements were performed using quantitative flow ratio (QFR) for pre‐perfusion assessment and verifying improvement.Results: The median creatinine level was 2.1 (inter‐quartile range 1.8–3.3), and mean eGFR was 48 ± 8 ml/min/1.73 m2 pre‐PCI. During the PCI procedure, OCT revealed 15 (52%) cases of abnormalities post‐dilation. There was no significant change in the creatinine level and eGFR in the short‐ or long‐term, and no major adverse events were observed.Conclusion: In non‐STEMI patients with high‐risk CKD who require revascularization, QFR and no contrast OCT‐guided ultra‐low contrast PCI may be performed safely without major adverse events.
- 25 March 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 97 (S2) , 1072-1079
Zero contrast optical coherence tomography‐guided percutaneous coronary intervention in patients with non‐ST segment elevation myocardial infarction and chronic kidney disease
Objectives: To investigate a strategy for ultra‐low volume contrast percutaneous coronary intervention (PCI) with the aims of preserving renal function and observing the 90‐day clinical endpoint in patients with non‐ST‐elevated myocardial infarction (non‐STEMI) and chronic kidney disease (CKD).Background: The feasibility, safety, and clinical utility of PCI with ultra‐low radio‐contrast medium in patients with non‐STEMI and CKD are unknown.Methods: A total of 29 patients with non‐STEMI and CKD (estimated glomerular filtration rate [eGFR] of ≤60 ml/min/1.73 m2) were included. Ultra‐low volume contrast PCI was performed after minimal contrast coronary angiography using zero contrast optical coherence tomography (OCT) guidance. Pre‐ and post‐PCI angiographic measurements were performed using quantitative flow ratio (QFR) for pre‐perfusion assessment and verifying improvement.Results: The median creatinine level was 2.1 (inter‐quartile range 1.8–3.3), and mean eGFR was 48 ± 8 ml/min/1.73 m2 pre‐PCI. During the PCI procedure, OCT revealed 15 (52%) cases of abnormalities post‐dilation. There was no significant change in the creatinine level and eGFR in the short‐ or long‐term, and no major adverse events were observed.Conclusion: In non‐STEMI patients with high‐risk CKD who require revascularization, QFR and no contrast OCT‐guided ultra‐low contrast PCI may be performed safely without major adverse events.